We are live on ! Find out more
XLVS

POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS

Delisted

XLVS was delisted on the 22nd of March, 2011.

0 hedge funds and large institutions have $0 invested in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 10 (-1)

100% less capital invested

Capital invested by funds: $5K → $0 (-$5K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NR
Newfound Research
Massachusetts
-$5K
Name Holding Trade Value Shares
Change
Change in
Stake
NR
1
Newfound Research
Massachusetts
-$5K -52 Closed

XLVS Hedge Fund Activity: Q2 2020 in Review

0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) for Q2 2020, worth a combined $0 — down 100% from $5K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of XLVS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Newfound Research, exiting entirely with an estimated $5K sold.

  • 0 institutional investors held POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) as of Q2 2020, down from 1 in Q1 2020.
  • Funds reported $0 of POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO positions in Q2 2020 and 1 closed out, a net change of -1 holder.
  • The largest POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO seller in Q2 2020 was Newfound Research, an estimated $5K sold.

Based on aggregated 13F filings for Q2 2020.